AKT1 and lung carcinoma: Furthermore, LIQ suppressed levels of PI3K, Akt, and mTOR in lung cancer cells, suggesting that this compound induced anti-tumor activities by the inhibition of PI3K/Akt/mTOR signaling pathways [110].